Pyrazole → HCID 16722360, compound
Reaction equation
Cl[C:2]1[O:6][N:5]=[C:4]([C:7]2[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=2)[C:3]=1[C:13]1[O:17][C:16]([C:18]2[CH:23]=[CH:22][C:21]([N:24]3[CH2:29][CH2:28][O:27][CH2:26][CH2:25]3)=[CH:20][C:19]=2[O:30][CH3:31])=[N:15][N:14]=1.[NH:32]1[CH:36]=[CH:35][CH:34]=[N:33]1>>[CH3:31][O:30][C:19]1[CH:20]=[C:21]([N:24]2[CH2:29][CH2:28][O:27][CH2:26][CH2:25]2)[CH:22]=[CH:23][C:18]=1[C:16]1[O:17][C:13]([C:3]2[C:4]([C:7]3[CH:12]=[CH:11][CH:10]=[CH:9][CH:8]=3)=[N:5][O:6][C:2]=2[N:32]2[CH:36]=[CH:35][CH:34]=[N:33]2)=[N:14][N:15]=1Participants
3
Procedure
As described for example 106, 4-{4-[5-(5-chloro-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-3-methoxy-phenyl}-morpholine (100 mg, 0.23 mmol) using pyrazole instead of dimethylamine hydrochloride was converted to the title compound (85 mg, 79%) which was obtained as an off-white solid. MS: m/e=471.3 [M+H]+.
Sources & evidence
- ORD record
- ord-bfc6984a571d46e5bddc7026b4ae05c3
- Source dataset
- uspto-grants-2009_06
- Patent number
- US07541372B2
Reaction notes
Loading…